 |
5 Diseases |  |
0 Trials |
|
0 Trials |  |
24 News |  |
- |||| LGD-6972 / Ligand
Trial completion, Trial primary completion date: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Jan 12, 2018
P2, N=148, Completed, Sponsor: Ligand Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Jun 2017
- ||| LGD-6972 / Ligand
Enrollment closed: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Feb 27, 2017
P2, N=148, Active, not recruiting, Sponsor: Ligand Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Jun 2017 Recruiting --> Active, not recruiting
- |||| LGD-6972 / Ligand
Enrollment open: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Sep 12, 2016
P2, N=148, Recruiting, Sponsor: Ligand Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| LGD-6972 / Ligand
New P2 trial: A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Aug 2, 2016
P2, N=148, Not yet recruiting, Sponsor: Ligand Pharmaceuticals
- | LGD-6972 / Ligand
Trial completion: A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation (clinicaltrials.gov) - May 18, 2016
P1, N=12, Completed, Sponsor: Ligand Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- LGD-6972 / Ligand
Enrollment closed: A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation (clinicaltrials.gov) - May 6, 2016
P1, N=12, Active, not recruiting, Sponsor: Ligand Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- LGD-6972 / Ligand
Enrollment open: A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation (clinicaltrials.gov) - Mar 25, 2016
P1, N=8, Recruiting, Sponsor: Ligand Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- LGD-6972 / Ligand
New P1 trial: A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation (clinicaltrials.gov) - Feb 3, 2016
P1, N=8, Not yet recruiting, Sponsor: Ligand Pharmaceuticals
- | LGD-6972 / Ligand
Trial completion: L6972-02: Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (clinicaltrials.gov) - Jun 11, 2015
P1, N=48, Completed, Sponsor: Ligand Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- LGD-6972 / Ligand
Enrollment closed: L6972-02: Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (clinicaltrials.gov) - Apr 10, 2015
P1, N=48, Active, not recruiting, Sponsor: Ligand Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- LGD-6972 / Ligand
Enrollment open: L6972-02: Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (clinicaltrials.gov) - Oct 27, 2014
P1, N=48, Recruiting, Sponsor: Ligand Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| LGD-6972 / Ligand
Trial completion: Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Sep 28, 2014
P1, N=56, Completed, Sponsor: Ligand Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | LGD-6972 / Ligand
New P1 trial: L6972-02: Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus (clinicaltrials.gov) - Sep 28, 2014
P1, N=48, Not yet recruiting, Sponsor: Ligand Pharmaceuticals
- LGD-6972 / Ligand
Enrollment closed: Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Mar 13, 2014
P1, N=56, Active, not recruiting, Sponsor: Ligand Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- LGD-6972 / Ligand
New P1 trial: Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Aug 7, 2013
P1, N=56, Active, not recruiting, Sponsor: Ligand Pharmaceuticals